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P27Kip1a b s t r a c t
Activation of the Notch3 cascade is involved in the development of pulmonary arterial hypertension
by stimulating the proliferation of vascular smooth muscle cells. However, the detailed molecular
mechanisms underlying this effect are still unclear. The present study aims to address this issue.
We demonstrated that over-expression of intracellular domain of the Notch3 receptor (NICD3) by
adenovirus transfection dramatically induced proliferation of primary cultured pulmonary artery
smooth muscle cells. This was accompanied with up-regulation of Hes1 protein and down-
regulation of p27Kip1 protein. More importantly, we observed that prior silencing of Hes1 with
siRNA blocked NICD3 over-expression-induced p27Kip1 reduction and cell proliferation. The present
study suggests that Hes1 lies downstream of NICD3 and particularly mediates Notch3 signaling-
induced proliferation of pulmonary arterial smooth muscle cells by down-regulation of p27Kip1
expression.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
Pulmonary arterial hypertension (PAH) is a clinical syndrome
characterized by sustained elevation of pulmonary arterial resis-
tance and pulmonary arterial pressure (PAP) leading to right heart
failure and death [1,2]. Pulmonary arterial remodeling, occurring
mostly in the distal pulmonary arteries, is a hallmark of all types
of PAH [3]. Excessive proliferation of pulmonary arterial smooth
muscle cells (PASMCs) is critical in the pathogenesis of pulmonary
artery remodeling [4]. During the transition of PASMCs from quies-
cent to proliferative types, multiple signaling cascades are acti-
vated and mediate the phenotype change [5,6]. Therefore, it is
important to clarify these pathways and exploring key targets to
suppress PASMCs proliferation.
Notch signaling is a highly conserved cascade and plays an
important role in determining cell proliferation and apoptosis [7].Notch is a group of transmembrane receptors consisting 4 mem-
bers (Notch 1–4), the ligand of Notch consists of 5 members
JAGGED 1/2 and DELTA 1/3/4 [8]. Upon ligand binding, the Notch
receptor is activated by two sequential steps of proteolytical cleav-
age. These processes release the intracellular domain of the Notch
receptor (NICD), which translocates into the nucleus and works
with the DNA-binding factor, CBF1/RBPJ to regulate the transcrip-
tion of particular target genes [9]. It has been shown that Hairy-
and-enhancer of split (Hes) and Hairy/Enhancer of Split-related
(Hrt; also known as Hey) gene families are down-stream targets
of NICD [10], which belong to the basic helix-loop-helix (bHLH)
transcriptional regulators and repress the transcription of target
genes such as p57 kip2 [11], p27Kip1 [12] and p21waf1/cip1 [13]
and affect cell fate decision.
Recent studies have shown that activation of Notch3 signaling
pathway is involved in the development of PAH by stimulation of
PASMCs proliferation [14,15]. Previous studies have reported that
activation of Notch 3 signaling promotes non-pulmonary artery
smooth muscle cells proliferation by suppressing the expression
of p27Kip1 [16,17]. Other Studies have demonstrated that activa-
tion of Notch3 promotes the proliferation of hepatocellular carci-
noma cells through up-regulation of Hes1 expression and
subsequent reduction of p27Kip1 [18]. However, it is unclear
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cascade-mediated PASMCs proliferation. To address these issues,
primary cultured PASMCs were transfected with adenovirus to
over-express NICD3, and cell proliferation was determined, molec-
ular mechanisms underlying this effect were further explored.
2. Materials and methods
2.1. Cell preparation and culture
Primary pulmonary arterial smooth muscle cells from
pulmonary arteries were prepared from Sprague–Dawley rats
(100–150 g). All animal care and experiments were performed in
accordance with the Guide for the Care and Use of Laboratory
Animals of Xi’an Jiaotong University Animal Experiment Center.
All protocols used in this study were approved by the Laboratory
Animal Care Committee of Xi’an Jiaotong University. Briefly, the
isolated pulmonary arteries were rapidly removed from eutha-
nized rats by CO2 overdose, washed in phosphate-buffered saline
(4 C), and then dipped into Dulbecco’s Modified Eagle Medium
(DMEM, Gibco) with 10% fetal bovine serum (FBS, Sijiqing),
100 U/ml penicillin, and 100 lg/ml streptomycin (complete
DMEM). A thin layer of the adventitia was carefully stripped off
with fine forceps, and the endothelium was removed by gently
scratching the intima surface with a surgical blade. Next, pul-
monary arteries were cut into 1 mm tissue blocks and placed into
a culture flask and incubated at 37 C in an atmosphere of 95% air
and 5% CO2 till cells reaching 80% confluence. Then cells were pas-
saged using 0.25% trypsin. Cells between 4 and 6th passage were
used in the study. To test the purity of smooth muscle cells, cells
were stained with 40,60-diamidino-2-phenylindole (DAPI,
Invitrogen) and FITC-labeled anti-smooth muscle a-actin antibody
(Sigma) for nucleus and smooth muscle actin, respectively.
Fluorescence microscope images indicated that cells contained
more than 94% of smooth muscle cells (data not shown here).
Before each experiment, cells were incubated in 1% FBS-DMEM
overnight to minimize serum-induced effect on the cells, and cells
viability was more than 95% determined by trypan blue staining.
2.2. Adenoviral transfection
NICD3 and null adenovirus were provided by Vector Biolabs
(Mavelm). Transfection was performed at a multiplicity of infec-
tion of 100 plaque-forming units in 2 ml (6 mm culture dishes)
DMEM for 48 h at 37 C, 5% CO2 in a humidified incubator before
harvesting and analysis.
2.3. siRNA transfection
To silence the expression of Hes1 protein, PASMCs were trans-
fected with sequence-specific or non-targeting control siRNA
(Dharmacon) using LipofectamineTM 2000 reagent (Invitrogen) as
described previously [19]. Briefly, cells were cultured until they
reached 30–40% confluence; siRNA and Lipofectamine were diluted
in serum-free DMEM separately and incubated for 5 min at room
temperature. siRNA was mixed with Lipofectamine and incubated
at room temperature for 20 min. Then, the complex of siRNA and
Lipofectamine was added into cells and cells were cultured for
48 h at 37 C, 5% CO2 in a humidified incubator. Effects of siRNA
transfection were analyzed using Western blotting.
2.4. Brdu incorporation assay
To examine PASMCs proliferation, the rate of BrdU incorpora-
tion was determined using BrdU ELISA Kit (Maibio) according tothe manufacturer instructions. Briefly, cells were seeded into 96-
well plate at a density of 5  103 cells/well, then BrdU labeling
reagent was added to the wells and incubated for 2 h at 37 C.
Next, cells were denatured with FixDenat solution for 30 min at
room temperature, and followed by incubating with anti-BrdU
mAbs conjugated to peroxidase for 90 min at room temperature.
After removing antibody conjugate, substrate solution was added
for reaction of 10 min. The absorbance at 370 nm was determined
with a microplate reader (Bio-Rad). The blank corresponded to
100 lL of culture medium with or without BrdU.
2.5. Western blotting
The cultured cells were washed twice with ice-cold PBS and
lysed on ice with RIPA lysis buffer containing freshly added pro-
tease and phosphatase inhibitor cocktails. After 15 min of incuba-
tion, cell lysate was centrifuged for 10 min (15,000  g) at 4 C;
supernatant was saved as total protein. Equivalent amounts of pro-
tein (30 lg) from each sample were separated on SDS–polyacry-
lamide gels, then transferred to nitrocellulose membranes (Bio-
Rad). Monoclonal antibodies against Notch3 (Abcam, 1:500 dilu-
tion) and Hes1 (Cell Signaling Technology, 1:1000 dilution),
p27Kip1 (Cell Signaling Technology, 1:1000 dilution) as well as
polyclonal antibody against GAPDH (Sigma–Aldrich, 1:2000 dilu-
tion) were used according to the manufacturer instructions.
Horseradish peroxidase-conjugated goat anti-rabbit IgG was used
as secondary antibody (Sigma–Aldrich, 1:5000 dilution). Blots
were developed using ECL reagent kit (Millipore). The signal inten-
sity of the appropriate bands on the autoradiogram was calculated
by using Scion Image software (Scion).
2.6. Statistical analysis
Data are expressed as mean ± SEM. Statistical significance was
determined using one-way ANOVA followed by Tukey post hoc
test. P < 0.05 was considered to be significant between groups.
3. Results
3.1. Over-expression of NICD3 promotes PASMCs proliferation
To determine whether activation of Notch3 induces PASMCs
proliferation, NICD3 was over-expressed in cells by adenovirus
transfection. Fig. 1A shows that control PASMCs had almost no
basal NICD3 protein, and null adenovirus transfection did not
increase NICD3 protein level. PASMCs transfected with adenovirus
carrying NICD3 showed a dramatic increase in NICD3 protein level.
Fig. 1B indicates that cells with over-expressed NICD3 exhibited an
elevated proliferation assessed by BrdU incorporation assay, which
was 3-fold increase over control (P < 0.01), while transfection of
cells with null adenovirus did not affect cells proliferation. These
results suggest that activation of Notch3 effectively induces
PASMCs proliferation.
3.2. NICD3 up-regulates Hes1 expression and reduces p27Kip1
expression in PASMCs
To investigate the mechanisms underlying activation of Notch3
inducing PASMCs proliferation, down-stream targets of Notch3 sig-
naling pathway and cell cycle protein p27Kip1 were determined in
cells. As shown in Fig. 2A, cells transfected with NICD3 exhibited
an increased Hes1 protein expression, a 2.1-fold increase over con-
trol was achieved in cells (P < 0.01 versus control). Null adenovirus
transfection did not affect Hes1 protein level. Fig. 2B indicates that
protein level of p27Kip1 was reduced in NICD3 over-expressed
Fig. 1. Over-expression of NICD3 induces PASMCs proliferation. (A) The represen-
tative Western blot of NICD3 over-expression by adenovirus transfection in primary
cultured PASMCs (n = 3). (B) Over-expression of NICD3 induced PASMCs prolifer-
ation assessed by BrdU incorporation assay (n = 4 each group). *P < 0.01 versus
control cells.
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while null adenovirus transfection did not change p27Kip1 protein
level. These results suggest that activation of Notch3 modulates
Hes1 and P27Kip1 protein expression in PASMCs.Fig. 2. Over expression of NICD3 modulates Hes1 and p27Kip1 expression. Primary cult
lysates were used for analysis protein expression of Hes1 (A) and p27 Kip1 (B). The repres
control group.3.3. Hes1 mediates NICD3-induced reduction of p27Kip1 in PASMCs
To determine whether induction of Hes1 specifically mediated
NICD3-induced p27Kip1 reduction, knockdown of Hes1 was
applied in the study. Since the basal level of Hes1 protein is pretty
low, we did not examine the silencing effect in normal PASMCs.
Fig. 3A indicates that prior transfection of cells with either non-
specific siRNA or Hes1 siRNA did not affect NICD3 adenovirus
transfection-induced NICD3 expression. As shown in Fig. 3B, prior
transfection of Hes1 siRNA inhibited NICD3-induced Hes1 expres-
sion and p27Kip1 reduction, Hes1 decreased from 2.2-fold increase
over control in NICD3 transfected cells to 0.30-fold increase over
control in NICD3 transfected cells with prior Hes1 silencing
(P < 0.01), this was accompanied with the change of p27Kip1 from
0.37-fold increase to 1.1-fold increase over control (P < 0.01). These
results suggest that up-regulation of Hes1 is responsible for over-
expression of NICD3-induced p27Kip1 reduction.3.4. Changes of Hes1/p27Kip1 mediated NICD3-induced PASMCs
proliferation
To examine whether the change of Hes1/p27Kip1 caused by
NICD3 over-expression is associated with NICD3-induced
PASMCs proliferation, BrdU incorporation was determined in cells
transfected with NICD3 adenovirus with or without prior silencing
Hes1. Fig. 4 shows that over-expression of NICD3 triggered a 2.90-
fold increase in cell proliferation compared with control (P < 0.01),
while knockdown of Hes1 by siRNA transfection partially sup-
pressed cells proliferation induced by NICD3 over-expression,
which decreased to 1.76-fold increase over control (P < 0.05 versus
NICD3-transfected cells). Non specific siRNA did not affect NICD3-
induced cell proliferation. These results suggest that Hes1-induced
p27Kip1 reduction mediates NICD3 stimulation of PASMCs
proliferation.ured PASMC were transfected with control (null) or NICD3 adenovirus for 48 h, cell
entative Western blot and quantification of bands are shown (n = 3) *P < 0.01 versus
Fig. 3. Up-regulation of Hes1 mediates NICD3-induced p27Kip1 down-regulation. (A) PASMCs were prior transfected with sequence specific or non-specific siRNA targeting
on Hes1 before adenovirus carrying NICD3 infection, Western blot shows that siRNA transfection did not affect NICD3 protein expression (n = 3). (B) Loss of Hes1 reversed
NICD3 over-expression-induced p27Kip1 protein reduction (n = 3). *P < 0.01 versus control group; #P < 0.01 versus NICD3 group.
Fig. 4. Knockdown of Hes1 blocks NICD3-induced PASMCs proliferation. PASMCs
were prior silenced with Hes1 siRNA and then infected with NICD3 adenovirus, cell
proliferation was determined using BrdU incorporation assay (n = 4). *P < 0.01,
**P < 0.05 versus control group; #P < 0.05 versus NICD3 group.
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In the present study, we provide direct evidence that activation
of Notch3 signaling by over-expression of NICD3 stimulates pri-
mary cultured PASMCs proliferation; this effect is coupled to
NICD3 up-regulation of Hes1 expression and subsequent down-
regulation of p27Kip1. The present study also suggests that target-
ing Notch3 cascade might be a novel strategy for the management
of PAH.
Notch3 receptor is predominantly expressed in arterial vascular
smooth muscle cells, and modulates multiple behaviors of vascular
smooth muscle cells including proliferation, apoptosis and migra-
tion [20,21]. It has been shown that Notch3-null mice is defected
in the vascular development [16], and Notch3 mutations are
responsible for heritable cerebral autosomal dominant arteriopa-
thy with subcortical infarcts and leukoencephalopathy (CADASIL)
syndrome with alterations in vascular smooth muscle cells
(VSMCs) [22]. Recent study has indicated that Notch3 missensemutations are identified in patients with PAH and verified that
these mutations are associated with PASMCs proliferation [15]. Li
et al. have found that Notch3 expression is elevated in clinic
patients with PAH; they further report that Notch3 knockout trans-
genic mice are resistant to hypoxia-induced PAH. On the other
hand, inhibition of Notch3 cleavage (activation) by gamma secre-
tase inhibitor blocks the occurrence of PAH in animal model by
suppression of PASMCs proliferation [14]. Our results provided
the direct evidence that over-expression of NICD3 (activation of
Notch3 signaling) caused PASMCs proliferation, and further con-
firmed above observation.
Upon Notch3 activation, released NICD3 translocates to
nucleus, where it forms complex with CBF-1/RBP-Jk to regulate tar-
get genes transcription [23] including Hes transcriptional repres-
sors [24–27]. Hes is a group of bHLH transcription factor
repressors, which negatively modulate cell cycle progression and
cell proliferation by regulating transcription of cell cycle proteins
[28]. Hes1 binds to the promoter of p27 Kip1and reduces
p27Kip1 expression in a variety of tumor cells [12,18] and non-
pulmonary vascular smooth muscle cells leading to these cells pro-
liferation [29,30]. The present study indicated that up-regulation of
Hes1 by over-expression of NICD3 also particularly mediated tran-
scriptional suppression of p27Kip1 in PASMCs.
p27Kip1 plays a critical role in regulating cell cycle progression
in mammalian cells. As a cyclin-dependent kinase (CDK) inhibitor,
p27Kip1 binds to and inhibits the function of cyclin E/CDK2 com-
plex, and further blocks cell cycle progression from G1 into S phase
and suppresses cell proliferation. The present study showed that
up-regulation of Hes1 was responsible for the reduction of
p27Kip1 protein level in NICD3 over-expressed PASMCs; however,
silencing Hes1 did not fully suppress PASMCs proliferation despite
the restoration of p27Kip1 protein level, suggesting that other
mechanisms independent of Hes1/p27Kip1 might be also involved
in the activation of Notch3-induced PASMCs proliferation. Giving
the fact that enhanced Notch3 signaling is associated with the pul-
monary vascular remodeling in clinic patients and a variety of ani-
mal model of PAH, the strategy that interfering Notch3 signaling
pathway might prevent or treat the development of PAH, it is
660 Y. Song et al. / FEBS Open Bio 5 (2015) 656–660worthy to test the effect and safety of this approach in clinic
patients with PAH.
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